Ou SH - Search Results

1

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

Ou SH, Zell JA, Ziogas A, Anton-Culver H. Ou SH, et al. Cancer. 2007 Oct 1;110(7):1532-41. doi: 10.1002/cncr.22938. Cancer. 2007. PMID: 17702091 Free article.

2

Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors.

Zell JA, Ou SH, Ziogas A, Anton-Culver H. Zell JA, et al. Among authors: ou sh. J Clin Oncol. 2005 Nov 20;23(33):8396-405. doi: 10.1200/JCO.2005.03.0312. J Clin Oncol. 2005. PMID: 16293870 Free article.

3

Natural history of stage I non-small cell lung cancer: implications for early detection.

Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Raz DJ, et al. Among authors: ou sh. Chest. 2007 Jul;132(1):193-9. doi: 10.1378/chest.06-3096. Epub 2007 May 15. Chest. 2007. PMID: 17505036

4

Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.

Zell JA, Ou SH, Ziogas A, Anton-Culver H. Zell JA, et al. Among authors: ou sh. Cancer. 2008 Jan 1;112(1):136-43. doi: 10.1002/cncr.23146. Cancer. 2008. PMID: 17960795 Free article.

5

Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.

Ou SH, Zell JA, Ziogas A, Anton-Culver H. Ou SH, et al. Cancer. 2008 May 1;112(9):2011-20. doi: 10.1002/cncr.23397. Cancer. 2008. PMID: 18361399 Free article.

6

Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.

Schiller JH, Larson T, Ou SH, Limentani S, Sandler A, Vokes E, Kim S, Liau K, Bycott P, Olszanski AJ, von Pawel J. Schiller JH, et al. Among authors: ou sh. J Clin Oncol. 2009 Aug 10;27(23):3836-41. doi: 10.1200/JCO.2008.20.8355. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597027 Clinical Trial.

7

Burkitt's lymphoma of the base of the tongue: a case report and review of the literature.

Feinberg SM, Ou SH, Gu M, Shibuya TY. Feinberg SM, et al. Among authors: ou sh. Ear Nose Throat J. 2007 Jun;86(6):356-60. Ear Nose Throat J. 2007. PMID: 17703817 Review.

8

Final Overall Survival and Long-Term Safety of Lorlatinib in Patients With ALK-Positive NSCLC From the Pivotal Phase 2 Study: A Brief Report.

Ou SI, Solomon BJ, Besse B, Bearz A, Lin CC, Chiari R, Camidge DR, Lin JJ, Abbattista A, Toffalorio F, Soo RA. Ou SI, et al. J Thorac Oncol. 2024 Nov 22:S1556-0864(24)02484-5. doi: 10.1016/j.jtho.2024.11.021. Online ahead of print. J Thorac Oncol. 2024. PMID: 39581380 Free article.

9

Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma.

Kroening G, Luo J, Evans MG, Adeyelu T, Ou SI, Arter ZL, Wise-Draper TM, Sukari A, Azmi AS, Braxton DR, Elliott A, Bryant DA, Oberley MJ, Kim C, Shapiro GI, French CA, Nagasaka M. Kroening G, et al. JCO Precis Oncol. 2024 Oct;8:e2400334. doi: 10.1200/PO.24.00334. Epub 2024 Oct 24. JCO Precis Oncol. 2024. PMID: 39447095 Free PMC article.

10

Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC).

Ou SH, Kilvert H, Candlish J, Lee B, Polli A, Thomaidou D, Le H. Ou SH, et al. Lung Cancer. 2024 Nov;197:107968. doi: 10.1016/j.lungcan.2024.107968. Epub 2024 Sep 29. Lung Cancer. 2024. PMID: 39368244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters